These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34323010)

  • 21. Calibrated automated thrombin generation measurement in clotting plasma.
    Hemker HC; Giesen P; Al Dieri R; Regnault V; de Smedt E; Wagenvoord R; Lecompte T; Béguin S
    Pathophysiol Haemost Thromb; 2003; 33(1):4-15. PubMed ID: 12853707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.
    White D; MacDonald S; Edwards T; Bridgeman C; Hayman M; Sharp M; Cox-Morton S; Duff E; Mahajan S; Moore C; Kirk M; Williams R; Besser M; Thomas W
    Int J Lab Hematol; 2021 Feb; 43(1):123-130. PubMed ID: 32892505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semi-automated thrombin dynamics applying the ST Genesia thrombin generation assay.
    Carlo A; Yan Q; Ten Cate H; De Laat-Kremers R; De Laat B; Ninivaggi M
    Front Cardiovasc Med; 2022; 9():912433. PubMed ID: 35958413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal thrombin generation in neonates in spite of prolonged conventional coagulation tests.
    Tripodi A; Ramenghi LA; Chantarangkul V; De Carli A; Clerici M; Groppo M; Mosca F; Mannucci PM
    Haematologica; 2008 Aug; 93(8):1256-9. PubMed ID: 18403390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies.
    Joly B; Barbay V; Borg JY; Le Cam-Duchez V
    Thromb Res; 2013 Sep; 132(3):386-91. PubMed ID: 23962423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram: A Nordic study.
    Ljungkvist M; Strandberg K; Berntorp E; Chaireti R; Holme PA; Larsen OH; Lassila R; Jouppila A; Szanto T; Zetterberg E
    Haemophilia; 2019 Mar; 25(2):334-342. PubMed ID: 30715788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study using thrombin generation and three different INR methods in patients on Vitamin K antagonist treatment.
    Riva N; Vella K; Meli S; Hickey K; Zammit D; Calamatta C; Makris M; Kitchen S; Ageno W; Gatt A
    Int J Lab Hematol; 2017 Oct; 39(5):482-488. PubMed ID: 28500649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How the direct oral anticoagulant apixaban affects thrombin generation parameters.
    Tripodi A; Padovan L; Veena C; Scalambrino E; Testa S; Peyvandi F
    Thromb Res; 2015 Jun; 135(6):1186-90. PubMed ID: 25895845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.
    Duchemin J; Pan-Petesch B; Arnaud B; Blouch MT; Abgrall JF
    Thromb Haemost; 2008 Apr; 99(4):767-73. PubMed ID: 18392335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thrombin generation test].
    Espitia O; Fouassier M
    Rev Med Interne; 2015 Oct; 36(10):690-3. PubMed ID: 26028157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous thrombin generation in whole blood: New applications for assessing activators and inhibitors of coagulation.
    Prior SM; Mann KG; Freeman K; Butenas S
    Anal Biochem; 2018 Jun; 551():19-25. PubMed ID: 29746819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system.
    Furugohri T; Sugiyama N; Morishima Y; Shibano T
    Thromb Haemost; 2011 Dec; 106(6):1076-83. PubMed ID: 22012070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental haemostasis. Impact for clinical haemostasis laboratories.
    Monagle P; Barnes C; Ignjatovic V; Furmedge J; Newall F; Chan A; De Rosa L; Hamilton S; Ragg P; Robinson S; Auldist A; Crock C; Roy N; Rowlands S
    Thromb Haemost; 2006 Feb; 95(2):362-72. PubMed ID: 16493500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q; Kim JE; Hyun J; Han KS; Kim HK
    Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Assessment of anti-factor Xa activity for heparin and related products by chromogenic assays and thrombin generation tests].
    Suzuki A; Kaneko M; Kanno N; Yatomi Y
    Rinsho Byori; 2013 Jul; 61(7):567-75. PubMed ID: 24205696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole Blood Thromboelastometry by ROTEM and Thrombin Generation by Genesia According to the Genotype and Clinical Phenotype in Congenital Fibrinogen Disorders.
    Szanto T; Lassila R; Lemponen M; Lehtinen E; Neerman-Arbez M; Casini A
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombin Generation Profile Using ST-Genesia after PEG-asparaginase in Pediatric Patients with Acute Lymphoblastic Leukemia.
    Ruiz-Llobet A; Gassiot S; Sarrate E; Zubicaray J; Rives S; Suleman W; Berrueco R
    Thromb Haemost; 2024 Oct; 124(10):973-985. PubMed ID: 38684189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determining the impact of instrument variation and automated software algorithms on the TGT in hemophilia and normalized plasma.
    Woodle SA; Shibeko AM; Lee TK; Ovanesov MV
    Thromb Res; 2013 Sep; 132(3):374-80. PubMed ID: 23953593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishing a reference range for thrombin generation using a standard plasma significantly improves assay precision.
    Bagot CN; Leishman E
    Thromb Res; 2015 Jul; 136(1):139-43. PubMed ID: 25956288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease Recurrence.
    Gomez-Rosas P; Pesenti M; Verzeroli C; Giaccherini C; Russo L; Sarmiento R; Masci G; Celio L; Minelli M; Gamba S; Tartari CJ; Tondini C; Giuliani F; Petrelli F; D'Alessio A; Gasparini G; Labianca R; Santoro A; De Braud F; Marchetti M; Falanga A;
    TH Open; 2021 Jan; 5(1):e56-e65. PubMed ID: 33585786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.